Clinical trial
SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
NCT02862067 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- January 16, 2018
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.